Navigation Links
Berman Calls Obama's Mexico City Policy Reversal an Important Step in Women's Rights, Health Care
Date:1/23/2009

VAN NUYS, Calif., Jan. 23 /PRNewswire-USNewswire/ -- Congressman Howard L. Berman (D-CA), chairman of the House Foreign Affairs Committee, said today President Obama's executive order repealing the Mexico City Policy is an important step in protecting women's rights and in improving health care worldwide.

"The President's action rights a wrong-headed policy that for eight years has hindered people in developing countries from having access to the contraceptives necessary to prevent unintended pregnancies, abortions, and the transmission of sexually transmitted infections, including HIV/AIDS," Berman said.

Known popularly as the Global Gag Rule, the Mexico City Policy prohibited federal funding for non-governmental organizations that discuss, counsel on, or provide abortions in developing countries. Berman observed that "this policy - which would violate the constitutional right to freedom of speech if placed on U.S.-based non-governmental organizations - applied even if abortion-related services were funded only with non-U.S. funds, and even if abortion was legal in the country in which services were provided."

"Repeal of these restrictions was long overdue," Berman noted, "and the action President Obama has taken is a clear signal that he intends to change how America works with the international community in solving global problems."


'/>"/>
SOURCE House Committee on Foreign Affairs
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Rulings Send Lawsuits Against State Farm, American Family Back to Court, Hagens Berman Sobol Shapiro Announces
2. Hagens Berman Sobol Shapiro: Judge Orders Double Damages, Issues Stinging Rebuke in Average Wholesale Price Case
3. Hagens Berman Sobol Shapiro Announces Investigation Into Marketing of Vytorin and Zetia
4. CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough
5. Hagens Berman: Eleven Defendants Settle in Average Wholesale Price Litigation
6. Hagens Berman Sobol Shapiro: Nationwide Class Action Certified in Average Wholesale Price Litigation
7. Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck
8. Hagens Berman Sobol Shapiro: Attorneys Representing Consumers Prepare for $12 Billion RICO Trial Against McKesson for Alleged Drug Price Manipulation
9. Hagens Berman Sobol Shapiro: Class Action Filed Against Spectranetics
10. Hagens Berman Files Class Action Against Bayer Healthcare Over Misleading Marketing Campaign
11. Hagens Berman Sobol Shapiro: McKesson Settles RICO Lawsuit for $350 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... ... 2017 partnership with The Jensie Gran Fondo of Marin. For the second year ... with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to provide our safe, ...
(Date:2/23/2017)... ... 23, 2017 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... Miami Beach to host its Swirl: Miami Wine Tasting Event on March 28, ...
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael ... “Mama June: From Not to Hot,” which will begin airing on February 24, 2017. ... to millions from the 2012 reality television series, “Here Comes Honey Boo Boo.” The ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO ... the National Institute for Health and Care Excellence (NICE) framework. The ... National Health Service (NHS) to search, order and purchase medical and healthcare-related content ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink ... publication where generations converge and explore the world from different perspectives. By providing ... enables readers to gain understanding, increase empathy, and find greater happiness. , ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 23, 2017 Non-alcoholic ... on the various drugs being developed for ... all the drugs that are in various ... The pipeline focuses on novel pharmacologic drugs ... stem cell therapies, recombinant proteins and RNA-based ...
(Date:2/24/2017)... -- Xynomic Pharmaceuticals, Inc., an oncology drug research and ... exclusive worldwide rights to develop, manufacture and commercialize ... hematological and solid tumors. To date ... clinical trials of Abexinostat in US, EU and ... completed, demonstrating that Abexinostat is clinically active in ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The latest research Autism Spectrum Disorder Drugs Price Analysis ... the global Autism Spectrum Disorder market. The research answers the ... drugs marketed for Autism Spectrum Disorder and their clinical attributes? How ...
Breaking Medicine Technology: